Literature DB >> 1058679

Regression of acromegaly following pituitary apoplexy.

P J Dunn, R A Donald, E A Espiner.   

Abstract

A case of acromegaly complicated by pituitary apoplexy is described. The pituitary apoplexy occurred while the patient was under investigation in a metabolic ward permitting full assessment of pituitary function both before and immediately after the event. This demonstrated a remarkably selective reduction in the plasma growth hormone concentration with preservation of other pituitary function excluding mild diabetes insipidus. The plasma growth hormone fell from values greater than 120 ng/ml to less than 4 ng/ml. The brisk inappropriate release of growth hormone observed on stimulation with thyrotrophic hormone releasing hormone, associated with a severe headache and the onset of pituitary apoplexy two days later raised the possibility of provocative tests of pituitary function precipitating pituitary apoplexy.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1058679     DOI: 10.1111/j.1445-5994.1975.tb03275.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  4 in total

1.  Primary chronic intrasellar haematoma: a case report.

Authors:  K Saito; M Takayasu; A Akabane; H Okabe; K Sugita
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

2.  Pituitary apoplexy in acromegaly, a long-term follow-up study in two patients.

Authors:  F Roelfsema; G van den Berg; H van Dulken; J D Veldhuis; S M Pincus
Journal:  J Endocrinol Invest       Date:  1998-05       Impact factor: 4.256

3.  Pituitary apoplexy associated with endocrine stimulation test: endocrine stimulation test, treatment, and outcome.

Authors:  Takahiro Yamamoto; Shigetoshi Yano; Jun-Ichiro Kuroda; Yu Hasegawa; Takuichiro Hide; Jun-Ichi Kuratsu
Journal:  Case Rep Endocrinol       Date:  2012-08-15

Review 4.  Multidisciplinary Management of Pituitary Apoplexy.

Authors:  Adriana Albani; Francesco Ferraù; Filippo Flavio Angileri; Felice Esposito; Francesca Granata; Felicia Ferreri; Salvatore Cannavò
Journal:  Int J Endocrinol       Date:  2016-12-15       Impact factor: 3.257

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.